CEO, Kachuck Enterprises Norm Kachuck, MD Consulting
Neurology
Dr. Norman J. Kachuck, MD
|
|
Give Review
Dr. Norman J. Kachuck practices Neurology. He researched medicine at Keck School of Medicine of USC. Keck School of Medicine of USC has a rank of 31 in research and a 72 in primary care He over the years received 1 awards: "Super Doctor". Norman Kachuck is a published MD. He has 19 publications published. The most current publication "Patient participation in treatment decision-making in the nursing home: the issue of competence."
Publications
- Registries, research, and regrets: is the FDA's post-marketing REMS process not adequately protecting patients?
- The interferon beta therapies for treatment of relapsing-remitting multiple sclerosis: are they equally efficacious? A comparative review of open-label studies evaluat...
- When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis.
- Managing conflicts of interest and commitment: academic medicine and the physician's progress.
- A phase 3 trial of extended release oral dalfampridine in multiple sclerosis.
- Reframing the conflicts of interest debacle: academic medicine, the healing alliance and the physician's moral imperative.
- Sustained release oral fampridine in the treatment of multiple sclerosis.
- Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.
- Dose comparison trial of sustained-release fampridine in multiple sclerosis.
- Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 t...
- Challenges and opportunities: what we are learning from the clinical natalizumab experience.
- Increased CXCL8 (IL-8) expression in Multiple Sclerosis.
- Characterization of monoclonal antibodies to human OC43.
- The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
- Immunological aspects of secondary progressive multiple sclerosis.
- Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer a...
- Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group.
- Patient participation in treatment decision-making in the nursing home: the issue of competence.
Schools
Keck School Of Medicine Of The Univ Of Southern California
LacUsc Medical Center
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Super Doctor
Education
-
University of Southern California - LAC+USC Medical Center -
Keck School of Medicine of USC
Hospital
-
Keck Hospital of USC
Helpful Reviews
Similar Doctors
|
|
Dr. John M. Ringman, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Peter Lorber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura A. Kalayjian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas J. Parziale, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul M. Vespa, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. John C. Mazziotta, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Gregory O. Walsh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Boniface O. Onubah, MD |
|
|
Dr. Aaron M. Carlson, MD |
|
|
Dr. Christine Hung, MD |
|
|
Dr. Han Lee, MD |
|
|
Dr. Aylin Y. Reid, MD |
|
|
Jill Shapira, NP |
|
|
Dr. Meko Y. Porter, DO
This Doctor is OpenDoctor Recommended.
|